Evoke Pharma and EVERSANA Announce Positive Findings from Second GIMOTI® Market Research Study
June 15, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, June 15, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases,...
Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®
June 08, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Announces Issuance of a New U.S. Patent Covering Methods of Use for Gimoti®
June 02, 2021 08:30 ET
|
Evoke Pharma, Inc.
New patent expands intellectual property protection for nasal delivery of metoclopramide and is expected to be FDA Orange Book listed SOLANA BEACH, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Evoke...
Evoke Pharma and EVERSANA Launch Social Media Campaign for Gimoti® Nasal Spray
May 27, 2021 08:30 ET
|
Evoke Pharma, Inc.
Evoke is committed to meeting patients online, where they search for answers New campaign leverages Facebook to satisfy significant unmet need for education and community SOLANA BEACH, Calif. and...
Evoke Pharma Appoints Vickie Reed to Board of Directors
May 14, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
Evoke Pharma Reports First Quarter 2021 Financial Results
May 12, 2021 16:05 ET
|
Evoke Pharma, Inc.
Nearly 293% growth of product sales, 235% growth of prescriptions and 87% increase in new prescribers for Gimoti®New notice of allowance from USPTO to expand Gimoti patent estateSOLANA BEACH, Calif.,...
Evoke Pharma to Report First Quarter 2021 Financial Results on May 12, 2021
May 05, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Receives Notice of Allowance from United States Patent and Trademark Office for a Method of Use Patent with Claims Covering Gimoti®
April 06, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Announces a Fireside Chat with Key Opinion Leaders on the Treatment of Gastroparesis
March 30, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a commercial stage specialty pharmaceutical company focused on treatments for gastrointestinal (GI)...
Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021 16:05 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases,...